Long-Term Results with Adjuvant Ozone Therapy in the Management of Chronic Pelvic Pain Secondary to Cancer Treatment
Type: Journal Article
Author: Bernardino Clavo, MD, PhD, *,†,‡,§,¶ Minerva Navarro, MD† Mario Federico, MD, PhD‡
Emma Borrelli, MD, PhD, k Ignacio J. Jorge, MD, PhD† Ivone Ribeiro, MD‡
Juan I. Rodr_ıguez-Melcon, MD, PhD, ‡ Miguel A. Caram_es , MD, †
Norberto Santana-Rodr_ıguez, MD, PhD§,kk,** and Francisco Rodr_ıguez-Esparrag_on, BSc, PhD*
Summary: Recently, we published a preliminary report about the potential benefit of adjuvant use of local and systemic ozone therapy (O3T) in the management of refractory pelvic pain secondary to cancer treatment, at 3 months after ozone administration. After that, several colleagues contacted us to ask for more details about the overall O3T schedule and an update of the results at longer follow-up times. The aim of this letter is to try to answer those questions.